These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15887527)

  • 1. Dynamic HIV/AIDS parameter estimation with application to a vaccine readiness study in southern Africa.
    Filter RA; Xia X; Gray CM
    IEEE Trans Biomed Eng; 2005 May; 52(5):784-91. PubMed ID: 15887527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When to initiate HIV therapy: a control theoretic approach.
    Jeffrey AM; Xia X; Craig IK
    IEEE Trans Biomed Eng; 2003 Nov; 50(11):1213-20. PubMed ID: 14619991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear control of a dynamic model of HIV-1.
    Ge SS; Tian Z; Lee TH
    IEEE Trans Biomed Eng; 2005 Mar; 52(3):353-61. PubMed ID: 15759565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of long-term HIV dynamics using semi-parametric non-linear mixed-effects models.
    Wu H; Zhang JT
    Stat Med; 2002 Dec; 21(23):3655-75. PubMed ID: 12436462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability.
    Ko JH; Kim WH; Chung CC
    IEEE Trans Biomed Eng; 2006 Mar; 53(3):380-6. PubMed ID: 16532764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameter identifiability and estimation of HIV/AIDS dynamic models.
    Wu H; Zhu H; Miao H; Perelson AS
    Bull Math Biol; 2008 Apr; 70(3):785-99. PubMed ID: 18247096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback control of a biodynamical model of HIV-1.
    Brandt ME; Chen G
    IEEE Trans Biomed Eng; 2001 Jul; 48(7):754-9. PubMed ID: 11442287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS researchers seek criteria for vaccines.
    Check E
    Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
    Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
    J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of open loop and closed loop drug administration strategies in the treatment of AIDS.
    Caetano MA; Yoneyama T
    An Acad Bras Cienc; 1999; 71(4 Pt 1):589-97. PubMed ID: 10683672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis depends on viral load. AIDS: frequently too much time is wasted].
    Fortschr Med; 1997 Jun; 115(16):14. PubMed ID: 9280745
    [No Abstract]   [Full Text] [Related]  

  • 16. Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization.
    Rabinowitz M; Myers L; Banjevic M; Chan A; Sweetkind-Singer J; Haberer J; McCann K; Wolkowicz R
    Bioinformatics; 2006 Mar; 22(5):541-9. PubMed ID: 16368772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Within-host virus models with periodic antiviral therapy.
    De Leenheer P
    Bull Math Biol; 2009 Jan; 71(1):189-210. PubMed ID: 19083064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy dramatically reduces viral load.
    AIDS Patient Care STDS; 1996 Apr; 10(2):131. PubMed ID: 11361695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.